全球人类细胞治疗原料市场规模、份额、趋势和成长分析报告（2026-2034年）

预计到 2034 年，用于细胞治疗的人类原料市场规模将从 2025 年的 50.4 亿美元达到 322.1 亿美元，并预计从 2026 年到 2034 年将以 22.89% 的复合年增长率增长。

受先进细胞疗法研发和商业化进程的推动，全球细胞治疗用人源原料市场正经历强劲成长。血清、生长因子和细胞培养基等人类来源的原料是细胞疗法生产的关键要素。再生医学和免疫疗法领域投资的增加也显着提升了市场需求。

关键成长要素包括临床试验的扩展、细胞疗法监管核准的增加以及对个人化医疗日益增长的关注。生物製药公司正在加强供应链，以确保获得高品质且符合规范的原材料。研究机构与产业相关人员之间合作的加强也进一步促进了市场发展。

展望未来，製造技术的进步以及CAR-T疗法和干细胞疗法的商业化将创造巨大的机会。随着对创新生物製药需求的不断增长，全球医疗保健领域用于细胞治疗的人源性原料市场预计将稳步扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球细胞疗法用人类成分市场：依产品划分

• 市场分析、洞察与预测
• 细胞培养基
• 细胞培养用血清
• 细胞培养添加剂
• 试剂和缓衝溶液
• 其他原料

第五章：全球细胞治疗用人类原料市场：依最终用途划分

• 市场分析、洞察与预测
• 生物製药和製药公司
• 合约研究组织 (CRO) 和合约生产组织 (CMO)
• 学术研究机构

第六章：全球细胞治疗用人类成分市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Actylis
  • ACROBiosystems
  • STEMCELL Technologies Inc
  • Grifols SA
  • Charles River Laboratories International Inc
  • RoosterBio Inc
  • PromoCell GmbH
  • Danaher Corporation
  • BioIVT LLC
  • GeminiBio（Gemini Bioproducts LLC）
  • Akron Biotech
  • AllCells LLC
  • CGT Global

The Cell Therapy Human Raw Materials Market size is expected to reach USD 32.21 Billion in 2034 from USD 5.04 Billion (2025) growing at a CAGR of 22.89% during 2026-2034.

The global cell therapy human raw materials market is witnessing strong growth driven by increasing research and commercialization of advanced cell-based therapies. Human-derived raw materials such as serum, growth factors, and cell culture media are essential in manufacturing cell therapies. Rising investments in regenerative medicine and immunotherapy are significantly boosting demand.

Major growth drivers include expanding clinical trials, increasing regulatory approvals for cell therapies, and rising focus on personalized medicine. Biopharmaceutical companies are strengthening supply chains to ensure high-quality and compliant raw materials. Growing collaborations between research institutions and industry players are further supporting market development.

In the future, advancements in manufacturing technologies and increasing commercialization of CAR-T and stem cell therapies will create significant opportunities. As demand for innovative biologics rises, the cell therapy human raw materials market is expected to expand steadily across global healthcare sectors.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Cell Culture Media
• Cell Culture Sera
• Cell Culture Supplements
• Reagents & Buffers
• Other Raw Materials

By End-Use

• Biopharmaceutical & Pharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutions

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Merck KGaA, Actylis, ACROBiosystems, STEMCELL Technologies Inc, Grifols SA, Charles River Laboratories International Inc, RoosterBio Inc, PromoCell GmbH, Danaher Corporation, BioIVT LLC, GeminiBio Gemini Bioproducts LLC, Akron Biotech, AllCells LLC, CGT Global
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CELL THERAPY HUMAN RAW MATERIALS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Cell Culture Media Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cell Culture Sera Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cell Culture Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Reagents & Buffers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Raw Materials Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CELL THERAPY HUMAN RAW MATERIALS MARKET: BY END-USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-use
• 5.2. Biopharmaceutical & Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. CROs & CMOs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Academic & Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CELL THERAPY HUMAN RAW MATERIALS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End-use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End-use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End-use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End-use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End-use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CELL THERAPY HUMAN RAW MATERIALS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Thermo Fisher Scientific Inc
  • 8.2.2 Merck KGaA
  • 8.2.3 Actylis
  • 8.2.4 ACROBiosystems
  • 8.2.5 STEMCELL Technologies Inc
  • 8.2.6 Grifols S.A
  • 8.2.7 Charles River Laboratories International Inc
  • 8.2.8 RoosterBio Inc
  • 8.2.9 PromoCell GmbH
  • 8.2.10 Danaher Corporation
  • 8.2.11 BioIVT LLC
  • 8.2.12 GeminiBio (Gemini Bioproducts LLC)
  • 8.2.13 Akron Biotech
  • 8.2.14 AllCells LLC
  • 8.2.15 CGT Global